Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02248701 · ClinicalTrials.gov registry record · Phase 2
Testosterone Plus Finasteride Treatment After Spinal Cord Injury
A Phase 2 study, sponsored by VA Office of Research and Development.
- Terminated
- Registry status
- Phase 2
- Development phase
- 33
- Enrollment target
NCT02248701: Clinical Trial Phase 2 study, sponsored by VA Office of Research and Development.
NCT02248701 is a Phase 2 study that was terminated before completion, run by VA Office of Research and Development. The registered enrollment target is 33 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02248701, a Phase 2 study, was terminated before completion, sponsored by VA Office of Research and Development.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 33 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether testosterone plus finasteride treatment will improve musculoskeletal health, neuromuscular function, body composition, and metabolic health in hypogonadal men who have experienced ambulatory dysfunction subsequent to incomplete spinal cord injury. The investigators hypothesize that this treatment will improve bone mineral density, enhance muscle size and muscle function, and improve body composition, without causing prostate enlargement.
Interventions
- DRUG Placebo pill
- DRUG Finasteride
- DRUG Testosterone Enanthate
- DRUG Placebo injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2017-04-27 |
| Est. Completion | 2021-08-13 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02248701
The ClinicalTrials.gov registry entry for NCT02248701 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo pill is the first listed.
NCT02248701 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02248701 about?
NCT02248701 is a clinical study titled "Testosterone Plus Finasteride Treatment After Spinal Cord Injury". The purpose of this study is to determine whether testosterone plus finasteride treatment will improve musculoskeletal health, neuromuscular function, body composition, and metabolic health in hypogonadal men who have experienced ambulatory dysfunction subsequent to incomplete spinal cord injury. Th...
What is the current status of trial NCT02248701?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 33 participants. The study started on 2017-04-27. Estimated completion is 2021-08-13.
What interventions are being tested in trial NCT02248701?
The interventions under investigation include: Placebo pill (DRUG), Finasteride (DRUG), Testosterone Enanthate (DRUG), Placebo injection (DRUG).
Who is sponsoring clinical trial NCT02248701?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.